In the CLL TME, IL-10 is highly expressed, which disrupts the synergy between NFAT and AP-1 through IL-10R-STAT3 signaling, thereby increasing the expression of PD-1 on CD8+ T cells and preventing T cells from playing an antitumor role (95, 96). Here, STAT3 is linked to B-cell chronic lymphocytic leukemia.